Glucagon-like peptide-1 receptor agonists improve cardiovascular outcomes and reduce mortality in patients with type 2 ...

Recent studies confirm that precision tools like OCT and AI-guided procedures are not only safer but also more effective in ...

According to a new study published in JAMA ,calprotectin may serve as a mechanistically informed biomarker for ...

Observational studies at the SCAI meeting favored the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound) over ...

During major vascular surgery, patients are at high risk for developing myocardial infarction and myocardial ischemia, and two risk-reduction strategies can be considered prior to surgery ...

New findings from multiple studies demonstrate that glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of ...

With both new and revised measures, the document’s authors aim to provide clinicians usable advice in a digestible format.

No-touch' vein harvesting significantly reduces the risk of graft failure up to three years after coronary artery bypass ...

Associated with reduced vein graft occlusion Coronary artery bypass grafting (CABG) remains a primary revascularisation strategy for complex coronary artery disease.1 The long term success of CABG ...